Loading...

225 posters, 34 videos, 18 topics, 14 sessions, 251 authors, 55 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

ISMICS 2024 Annual Meeting

29 May - 1 June, 2024 | Athens, Greece

ISMICS 2024 Annual Meeting banner

D.125

Endoscopic Mitral Valve Surgery In Octagenarians: Early And Mid-term Results

Part of Topic

Valve - Surgical Valves

ENDOSCOPIC MITRAL VALVE SURGERY IN OCTOGENARIANS: EARLY AND MID-TERM RESULTS 

R. Giusti, R. Margaryan, G. Bianchi, M. Solinas. Ospedale del Cuore Fondazione Monasterio, Massa, Italy. 


INTRODUCTION

Background: According to the guidelines, in centres with a high degree of procedural expertise, mitral valve repair is the treatment of choice. Longer life expectancy leads to an increase in cardiac surgery after the age of 80. 

Our purpose: The purpose of this study is to summarise the experience of endoscopic mitral valve surgery in octogenarians, evaluating the safety of the procedures and the short- and medium-term results in terms of life expectancy of life.

METHODS

From July 2015 to April 2023 35 patients with age of 80 or aboveunderwent isolated or concomitantmitro-tricuspid surgery via 4 cm right thoracotomy in totallyendoscopic setup. All electronichealth records were reviewed for this study and all data are available in our Institute'selectronic health system. Telephone calls were used for recent follow-up data and recent outpatient clinic records.

RESULTS

The mean age of the patients was82.7 years, 62% were male. Mitralvalve repair surgery wasperformed in 76% of the casesexamined. The average hospital stay at our Institute was 8.3 days. At a mean follow-up of 3 years, the survival rate was 88.2%. Only2 patients among the survivorshad moderate or greater residualmitral valve regurgitation. The mean NYHA class was 1.4 (onlythree patients had NYHA class 3 or higher).

CONCLUSIONS

 Endoscopic mitral valve surgery is a valid technique for special groups such asoctogenarians. It can produce excellent resultswith a good repair rate and less surgical trauma. Ourexperience showed safe feasibility, excellent earlyand good mid-term results. 


ismics2024 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.